1
TITLE: Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
AUTHORS: Ignace Vergote; Giovanni Scambia; David M O'Malley; Ben Van Calster; Sang Yoon Park; Josep M del Campo; Werner Meier; Aristotelis Bamias; Nicoletta Colombo; Robert M Wenham; Al Covens; Christian Marth; Mansoor Raza Mirza; Judith R Kroep; Haijun Ma; Cheryl A Pickett; Bradley J Monk; Sang Yoon Park; Yong Sang Song; Yulia Makarova; Joshua Trinidad; Hextan Yuen Sheung Ngan; Gerasimos Aravantinos; Joo Hyun Nam; Vera Gorbunova; Ludmila Krikunova; Duk Soo Bae; Jose Angel Arranz Arija; Mansoor Raza Mirza; Claudio Zamagni; Christos Papandreou; Francesco Raspagliesi; Alla Lisyanskaya; Ana Oaknin Benzaquen; Germana Tognon; Eugenia Ortega; Antonio Casado Herraez; Joseph Buscema; Andrew Green; Robert Burger; Dina Sakaeva; Andres Redondo Sanchez; Sharad Ghamande; Laurel King; Edgar Petru; Ulla Peen; Satoshi Takeuchi; Kimio Ushijima; Antonio Gonzalez Martin; Scott Kamelle; Michael Carney; Frédéric Forget; James Bentley; Jalid Sehouli; Paolo Zola; Hidenori Kato; Natalya Fadeeva; Evgeny Gotovkin; Vladimir Vladimirov; Margarita Romeo Marin; Eva Guerra Alia; Mark Shahin; Snehalkumar Bhoola; Krishnansu Tewari; Daniel Anderson; Brigitte Honhon; Joseph (Gino) Pelgrims; Amit Oza; Jesus Garcia Donas Jimenez; Vincent Hansen; Ivor Benjamin; Vincent Renard; Heidi Van den Bulck; Claudia Haenle; Georgios Koumakis; Harushige Yokota; Vadim Popov; William Bradley; Robert Wenham; Robert Reid; Donna McNamara; Richard Friedman; Joyce Barlin; Nicola Spirtos; Julia Chapman; Paul Sevelda; Manon Huizing; Caroline Lamot; Frédéric Goffin; Lionel D Hondt; Allan Covens; Silvana Spadafora; Beate Rautenberg; Toralf Reimer; Volker Möbus; Felix Hilpert; Martina Gropp Meier; Antonella Savarese; Sandro Pignata; Francesco Verderame; ...More
PUBLISHED: 2019, SOURCE: The Lancet Oncology, VOLUME: 20, ISSUE: 6
INDEXED IN: Scopus CrossRef: 30
2
TITLE: ZoptEC: Phase III randomized controlled study comparing zoptarelin with doxorubicin as second line therapy for locally advanced, recurrent, or metastatic endometrial cancer (NCT01767155).
AUTHORS: David Scott Miller ; Giovanni Scambia; Igor Bondarenko; Anneke M Westermann; Ana Oaknin; Amit M Oza; Alla Sergeevua Lisyanskaya; Ignace Vergote; Robert Michael Wenham; Sarah Madhu Temkin; Hani Gabra;
PUBLISHED: 2018, SOURCE: Journal of Clinical Oncology, VOLUME: 36, ISSUE: 15_suppl
INDEXED IN: CrossRef: 23
3
TITLE: Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer - Results from two randomised studies  Full Text
AUTHORS: Thomas Hogberg; Mauro Signorelli; Carlos Freire de Oliveira; Roldano Fossati; Andrea Alberto Lissoni; Bengt Sorbe; Hakan Andersson; Seija Grenman; Caroline Lundgren; Per Rosenberg; Karin Boman; Bengt Tholander; Giovanni Scambia; Nicholas Reed; Gennaro Cormio; Germana Tognon; Jackie Clarke; Tomasz Sawicki; Paolo Zola; Gunnar Kristensen;
PUBLISHED: 2010, SOURCE: EUROPEAN JOURNAL OF CANCER, VOLUME: 46, ISSUE: 13
INDEXED IN: Scopus WOS CrossRef